Skip to search formSkip to main contentSkip to account menu

TOK 8801

Known as: Imidazo(2,1-b)thiazole-2-carboxamide, 5,6-dihydro-3,6,6-trimethyl-N-(2-phenylethyl)-, TOK-8801 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesThiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Ameliorative effect of a novel immunomodulator, TOK-8801, on spontaneous autoimmune disease in MRL/I mice
1990
1990
Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type…
1989
1989
Immunomodulatory activity of the newly synthesized compound TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide).
The in vitro and in vivo effects of the newly synthesized compound TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)